A Phase 1 study of probiotic R-2487 in Rheumatoid Arthritis

Study Description

Evaluating the Safety and Effects of an Oral Probiotic in Rheumatoid Arthritis Patients

Study Details

Registry ID:

NCT05961592

Conditions:

Arthritis, Rheumatoid

Phase:

Phase 1

Target Enrollment:

73 participants

Start Date:

October 19, 2023

Age Range:

18–75 years

Healthy Volunteers:

No

Study Locations (7 sites)

• AP Medical Research
  Miami, FloridaUnited States, United States
• Edward Jenner Research
  Plantation, FloridaUnited States, United States
• St.Jude Clinical Research
  Doral, FloridaUnited States, United States
• Dartmouth Hitchcock Medical Center (DHMC)
  Lebanon, New HampshireUnited States, United States
• Altoona Center for Research
  Duncansville, PennsylvaniaUnited States, United States
• Prolato Clinical Research Center
  Houston, TexasUnited States, United States
• University of California, San Diego
  San Diego, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →